Pulsed–dose rate brachytherapy with concomitant chemotherapy and interstitial hyperthermia in patients with recurrent head-and-neck cancer


      Purpose: We attempted in our clinic to evaluate the efficacy and feasibility of a simultaneous application of a cis-platinum–based chemotherapy and interstitial hyperthermia to interstitial pulsed–dose rate (PDR) brachytherapy in patients with recurrent head-and-neck cancer. Methods and Materials: Between April 1999 and September 2001, 15 patients with recurrent head-and-neck cancer were treated with PDR brachytherapy, chemotherapy, and interstitial hyperthermia. All patients had received prior radiation therapy. A dose per pulse of 0.46 to 0.55 Gy was given up to a median total dose of 55 Gy. Simultaneously to the PDR brachytherapy, chemotherapy was given with cis-platinum 20 mg/m2 as a short i.v. infusion each day and 5-fluorouracil 800 mg/m2 by continuous infusion from Day 1 to Day 5. After the PDR brachytherapy was finished, all patients were treated with a single session of interstitial hyperthermia. Results: All the patients could receive the whole treatment. After treatment, only mild oral mucositis occurred. One patient developed soft tissue ulceration. None of the patients developed osteoradionecrosis. After a median follow-up of 6 months, the local tumor control rate was 80% (12 of 15), and the 2-year overall survival was 67% (10 of 15). Conclusions: The intensification of the interstitial PDR brachytherapy with chemotherapy and hyperthermia is feasible and safe, and the preliminary results are encouraging.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Brachytherapy
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Jovanovic A
        • van der Tol I.G
        • Kostense P.J
        • et al.
        Second respiratory and upper digestive tract cancer following oral squamous cell carcinoma.
        Eur J Cancer B Oral Oncol. 1994; 30B: 225-229
        • Lippman S.M
        • Hong W.K
        Second malignant tumors in head and neck squamous cell carcinoma.
        Int J Radiat Oncol Biol Phys. 1989; 17: 691-694
        • Ridge J.A
        Squamous cancer of the head and neck.
        Semin Oncol. 1993; 20: 419-429
        • Jensen P.T
        • Roed H
        • Engelholm S.A
        • et al.
        Pulsed dose rate (PDR) brachytherapy as salvage treatment of locally advanced or recurrent gynecologic cancer.
        Int J Radiat Oncol Biol Phys. 1998; 42: 1041-1047
        • Levendag P.C
        • Schmitz P.I
        • Jansen P.P
        • et al.
        Fractionated high-dose-rate and pulsed-dose-rate brachytherapy.
        Int J Radiat Oncol Biol Phys. 1997; 38: 497-506
        • Peiffert D
        • Castelain B
        • Thomas L
        • et al.
        Pulsed dose rate brachytherapy in head and neck cancers. Feasibility study of a French cooperative group.
        Radiother Oncol. 2001; 58: 71-75
        • de Pree C
        • Popowski Y
        • Weber D
        • et al.
        Feasibility and tolerance of pulsed dose rate interstitial brachytherapy.
        Int J Radiat Oncol Biol Phys. 1999; 43: 971-976
        • Strnad V
        • Lotter M
        • Grabenbauer G
        • et al.
        Early results of pulsed-dose-rate interstitial brachytherapy for head and neck malignancies after limited surgery.
        Int J Radiat Oncol Biol Phys. 2000; 46: 27-30
        • Emami B
        • Scott C
        • Perez C.A
        • et al.
        Phase III study of interstitial thermoradiotherapy compared with interstitial radiotherapy alone in the treatment of recurrent or persistent human tumors. A prospectively controlled randomized study by the Radiation Therapy Group.
        Int J Radiat Oncol Biol Phys. 1996; 34: 1097-1104
        • Schreiber D.P
        • Overett T.K
        Interstitial hyperthermia and iridium-192 treatment alone vs. interstitial iridium-192 treatment/hyperthermia and low dose cisplatinum infusion in the treatment of locally advanced head and neck malignancies.
        Int J Radiat Oncol Biol Phys. 1995; 33: 429-436
        • Serin M
        • Erkal H.S
        • Cakmak A
        Radiation therapy, cisplatin and hyperthermia in combination in management of patients with recurrent carcinomas of the head and neck with metastatic cervical lymph nodes.
        Int J Hyperthermia. 1999; 15: 371-381
        • Wu A
        • Ulin K
        • Sternick E.S
        A dose of homogeneity index for evaluating 192 Ir interstitial breast implants.
        Med Phys. 1988; 15: 104-107
        • Vokes E.E
        • Haraf D.J
        • Kies M.S
        The use of concurrent chemotherapy and radiotherapy for locoregionally advanced head and neck cancer.
        Semin Oncol. 2000; 27: 34-38
        • Chen T.Y
        • Emrich L.J
        • Driscroll D.L
        The clinical significance of pathological findings in surgically resected margins of the primary tumor in head and neck carcinoma.
        Int J Radiat Oncol Biol Phys. 1987; 13: 833-837
        • Vikram B
        • Strong E.W
        • Shah J.P
        • et al.
        Failure at the primary site following multimodality treatment in advanced head and neck cancer.
        Head Neck Surg. 1984; 6: 720-723
        • Weppelmann B
        • Wheeler R.H
        • Peters G.E
        • et al.
        Treatment of recurrent head and neck cancer with 5-fluorouracil, hydroxyurea, and reirradiation.
        Int J Radiat Oncol Biol Phys. 1992; 22: 1051-1056
        • Nguyen N.P
        • Sallah S
        Combined chemotherapy and radiation in the treatment of locally advanced head and neck cancers.
        In Vivo. 2000; 14: 35-39
        • Pignon J.P
        • Bourhis J
        • Domenge C
        • et al.
        Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma.
        Lancet. 2000; 355: 949-955
        • Urba S.G
        Concurrent chemoradiotherapy in head and neck cancer.
        Curr Oncol Rep. 1999; 1: 105-109
        • Amichetti M
        • Graiff C
        • Fellin G
        • et al.
        Cisplatin, hyperthermia, and radiation (trimodal therapy) in patients with locally advanced head and neck tumors.
        Int J Radiat Oncol Biol Phys. 1993; 26: 801-807
        • Sakurai H
        • Mitsuhashi N
        • Tamaki Y
        • et al.
        Clinical application of low dose-rate brachytherapy combined with simultaneous mild temperature hyperthermia.
        Anticancer Res. 2001; 21: 679-684
      1. Feyerabend T, Steeves R, Wiedemann GJ, et al. Local hyperthermia, radiation, and chemotherapy in locally advanced malignancies. Oncology 1996;53(3):214–120.

        • Pfeffer M.R
        • Teicher B.A
        • Holden S.A
        • et al.
        The interaction of cisplatin plus etoposide with radiation ± hyperthermia.
        Int J Radiat Oncol Biol Phys. 1990; 19: 1439-1447
        • Konings A.W
        • Hettinga J.V
        • Lemstra W
        • et al.
        Sensitizing for cis-diamminedichloroplatinum(II) action by hyperthermia in resistant cells.
        Int J Hyperthermia. 1993; 9: 553-562
        • Fu K.K
        • Newman H
        • Phillips T.L
        Treatment of locally recurrent carcinoma of the nasopharynx.
        Radiology. 1975; 117: 425-431
        • Pryzant R.M
        • Wendt C.D
        • Delclos L
        • et al.
        Re-treatment of nasopharyngeal carcinoma in 53 patients.
        Int J Radiat Oncol Biol Phys. 1992; 22: 941-947
        • Wang C.C
        • McIntyre J
        Re-irradiation of laryngeal carcinoma—Techniques and results.
        Int J Radiat Oncol Biol Phys. 1993; 26: 783-785
        • Stevens Jr, K.R
        • Britsch A
        • Moss W.T
        High-dose reirradiation of head and neck cancer with curative intent.
        Int J Radiat Oncol Biol Phys. 1994; 29: 687-698
        • Hartsell W.F
        • Thomas Jr, C.R
        • Murthy A.K
        • et al.
        Pilot study for the evaluation of simultaneous cisplatin/5-fluorouracil infusion and limited radiation therapy in regionally recurrent head and neck cancer (EST P-C385).
        Am J Clin Oncol. 1994; 17: 338-343
        • Haraf D.J
        • Weichselbaum R.R
        • Vokes E.E
        Re-irradiation with concomitant chemotherapy of unresectable recurrent head and neck cancer.
        Ann Oncol. 1996; 7: 913-918